← Back to All Filings

DaVita Director Receives Routine Stock Grant

Low SignificanceNovember 17, 2025 at 7:02:04 PM EST

DAVITA INC.

$DVA4CIK: 0000927066

Subscribe to track DVA

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

DaVita Director Receives Routine Stock Grant

Company: DAVITA INC. (DVA) Form: 4 | Filed: 2025-11-17 Significance: Low

Insider: Schoppert Wendy Lee Title: Director | Relationship: Director

Transaction: • Type: Grant • Shares: 411 • Price: $0.00 • Value: $0 • Owned After: 3,305

Key Insight: A director received a routine, non-cash stock award, a common form of compensation with minimal market impact.

Market Context: This grant represents a negligible 0.00057% of shares outstanding for the $8.58B healthcare company.

Comprehensive Analysis

SEC Filing Analysis: DAVITA INC. (DVA)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: A director received a routine stock award as part of their compensation, a non-market transaction with negligible impact.
  • Market Impact: Neutral. This is a standard corporate action and does not signal a change in insider sentiment.

Company Information

FieldValue
CompanyDAVITA INC.
Ticker SymbolDVA
CIK0000927066
IndustryMisc. Health & Allied Services

Insider Information

FieldValue
NameSchoppert Wendy Lee
CIK0001321558
Title/PositionDirector
RelationshipDirector

Transaction Details

FieldValue
Form Type4
Transaction Date2025-11-15
Transaction CodeA (Award)
Security TypeCommon Stock
Shares Involved411
Price Per Share$0.00
Total Value$0
Shares Owned After3,305
Ownership TypeDirect (for this transaction)

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$0
% of Market Cap0.0%
Shares Transacted411
% of Shares Outstanding0.00057%
Post-Transaction Ownership3,305 shares (0.0046% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The transaction value is $0. For a company with an $8.58 billion market cap, this event is financially immaterial.
  • Ownership Concentration: The director's total holding of 3,305 shares remains a very small fraction (0.0046%) of the total shares outstanding.
  • Dilution Impact: The issuance of 411 new shares represents a negligible dilution of 0.00057% to existing shareholders.
  • Transaction Significance: The transaction is a routine grant, indicated by the 'A' code and $0 price. It falls far below the thresholds for moderate or high significance.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: Stock grants to directors are a standard form of compensation and are not typically interpreted as a market signal by investors.

Volume & Sentiment

  • Expected Volume Impact: None. As a non-market transaction, this filing will not directly influence trading volume.
  • Sentiment Indicator: Neutral. This action does not provide any bullish or bearish signals.

Additional Context

Transaction Notes

  • The transaction is an award (Code 'A') of common stock at no cost, which is typical for director compensation plans.
Topics:#SECFiling#InsiderTrading#DVA#DaVita#Form4#StockGrant#CorporateGovernance#StockMarket

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.